APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

HER2 Antibody Drug Conjugate

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global HER2 Antibody Drug Conjugate Industry Growth and Trends Forecast to 2032

Report ID 173998100120 December 202578 pages

Choose your research edition.

Industry ResearchHER2 Antibody Drug Conjugate Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal HER2 Antibody Drug Conjugate Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal HER2 Antibody Drug Conjugate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HER2 Antibody Drug Conjugate Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal HER2 Antibody Drug Conjugate Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global HER2 Antibody Drug Conjugate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for HER2 Antibody Drug Conjugate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for HER2 Antibody Drug Conjugate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HER2 Antibody Drug Conjugate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HER2 Antibody Drug Conjugate include RemeGen, Roche and Daiichi Sankyo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global HER2 Antibody Drug Conjugate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The HER2 Antibody Drug Conjugate market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HER2 Antibody Drug Conjugate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HER2 Antibody Drug Conjugate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global HER2 Antibody Drug Conjugate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

HER2 Antibody Drug Conjugate Market by Company

RemeGen

Roche

Daiichi Sankyo

HER2 Antibody Drug Conjugate Segment by Type

100mg/ bottle

440mg/ bottle

HER2 Antibody Drug Conjugate Segment by Application

Hospital

Clinic

Others

HER2 Antibody Drug Conjugate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HER2 Antibody Drug Conjugate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HER2 Antibody Drug Conjugate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HER2 Antibody Drug Conjugate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of HER2 Antibody Drug Conjugate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of HER2 Antibody Drug Conjugate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg/ bottle Table 2. Major Company of 440mg/ bottle Table 3. Global HER2 Antibody Drug Conjugate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (k units) Table 5. Global HER2 Antibody Drug Conjugate Sales Market Share in Volume by Type (2021-2026) Table 6. Global HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (US$ Million) Table 7. Global HER2 Antibody Drug Conjugate Sales Market Share in Value by Type (2021-2026) Table 8. Global HER2 Antibody Drug Conjugate Price by Type (2021-2026) & (US$/unit) Table 9. Global HER2 Antibody Drug Conjugate Sales by Type (2027-2032) & (k units) Table 10. Global HER2 Antibody Drug Conjugate Sales Market Share in Volume by Type (2027-2032) Table 11. Global HER2 Antibody Drug Conjugate Sales by Type (2027-2032) & (US$ Million) Table 12. Global HER2 Antibody Drug Conjugate Sales Market Share in Value by Type (2027-2032) Table 13. Global HER2 Antibody Drug Conjugate Price by Type (2027-2032) & (US$/unit) Table 14. North America HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (k units) Table 15. North America HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (US$ Million) Table 16. Europe HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (k units) Table 17. Europe HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (k units) Table 21. Latin America HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa HER2 Antibody Drug Conjugate Sales by Type (2021-2026) & (US$ Million) Table 24. HER2 Antibody Drug Conjugate Industry Trends Table 25. HER2 Antibody Drug Conjugate Industry Drivers Table 26. HER2 Antibody Drug Conjugate Industry Opportunities and Challenges Table 27. HER2 Antibody Drug Conjugate Industry Restraints Table 28. Global HER2 Antibody Drug Conjugate Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global HER2 Antibody Drug Conjugate Revenue Market Share by Company (2021-2026) Table 30. Global HER2 Antibody Drug Conjugate Sales by Company (2021-2026) & (k units) Table 31. Global HER2 Antibody Drug Conjugate Sales Share by Company (2021-2026) Table 32. Global HER2 Antibody Drug Conjugate Market Price by Company (2021-2026) & (US$/unit) Table 33. Global HER2 Antibody Drug Conjugate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global HER2 Antibody Drug Conjugate Major Company Production Sites and Headquarters Table 35. Global HER2 Antibody Drug Conjugate Company, Product Type & Application Table 36. Global HER2 Antibody Drug Conjugate Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global HER2 Antibody Drug Conjugate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global HER2 Antibody Drug Conjugate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global HER2 Antibody Drug Conjugate Sales by Region (2021-2026) & (k units) Table 41. Global HER2 Antibody Drug Conjugate Sales Market Share in Volume by Region (2021-2026) Table 42. Global HER2 Antibody Drug Conjugate Sales by Region (2021-2026) & (US$ Million) Table 43. Global HER2 Antibody Drug Conjugate Sales Market Share in Value by Region (2021-2026) Table 44. Global HER2 Antibody Drug Conjugate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global HER2 Antibody Drug Conjugate Sales by Region (2027-2032) & (k units) Table 46. Global HER2 Antibody Drug Conjugate Sales Market Share in Volume by Region (2027-2032) Table 47. Global HER2 Antibody Drug Conjugate Sales by Region (2027-2032) & (US$ Million) Table 48. Global HER2 Antibody Drug Conjugate Sales Market Share in Value by Region (2027-2032) Table 49. Global HER2 Antibody Drug Conjugate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global HER2 Antibody Drug Conjugate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (k units) Table 52. Global HER2 Antibody Drug Conjugate Sales Market Share in Volume by Application (2021-2026) Table 53. Global HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (US$ Million) Table 54. Global HER2 Antibody Drug Conjugate Sales Market Share in Value by Application (2021-2026) Table 55. Global HER2 Antibody Drug Conjugate Price by Application (2021-2026) & (US$/unit) Table 56. Global HER2 Antibody Drug Conjugate Sales by Application (2027-2032) & (k units) Table 57. Global HER2 Antibody Drug Conjugate Sales Market Share in Volume by Application (2027-2032) Table 58. Global HER2 Antibody Drug Conjugate Sales by Application (2027-2032) & (US$ Million) Table 59. Global HER2 Antibody Drug Conjugate Sales Market Share in Value by Application (2027-2032) Table 60. Global HER2 Antibody Drug Conjugate Price by Application (2027-2032) & (US$/unit) Table 61. North America HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (k units) Table 62. North America HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (US$ Million) Table 63. Europe HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (k units) Table 64. Europe HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (k units) Table 68. Latin America HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa HER2 Antibody Drug Conjugate Sales by Application (2021-2026) & (US$ Million) Table 71. RemeGen Company Information Table 72. RemeGen Business Overview Table 73. RemeGen HER2 Antibody Drug Conjugate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. RemeGen HER2 Antibody Drug Conjugate Product Portfolio Table 75. RemeGen Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche HER2 Antibody Drug Conjugate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Roche HER2 Antibody Drug Conjugate Product Portfolio Table 80. Roche Recent Development Table 81. Daiichi Sankyo Company Information Table 82. Daiichi Sankyo Business Overview Table 83. Daiichi Sankyo HER2 Antibody Drug Conjugate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Daiichi Sankyo HER2 Antibody Drug Conjugate Product Portfolio Table 85. Daiichi Sankyo Recent Development Table 86. North America HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 87. North America HER2 Antibody Drug Conjugate Sales by Country (2021-2026) & (k units) Table 88. North America HER2 Antibody Drug Conjugate Sales Market Share by Country (2021-2026) Table 89. North America HER2 Antibody Drug Conjugate Sales Forecast by Country (2027-2032) & (k units) Table 90. North America HER2 Antibody Drug Conjugate Sales Market Share Forecast by Country (2027-2032) Table 91. North America HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America HER2 Antibody Drug Conjugate Market Size by Country (2021-2026) & (US$ Million) Table 93. North America HER2 Antibody Drug Conjugate Market Share by Country (2021-2026) Table 94. North America HER2 Antibody Drug Conjugate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America HER2 Antibody Drug Conjugate Market Share Forecast by Country (2027-2032) Table 96. Europe HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. Europe HER2 Antibody Drug Conjugate Sales by Country (2021-2026) & (k units) Table 98. Europe HER2 Antibody Drug Conjugate Sales Market Share by Country (2021-2026) Table 99. Europe HER2 Antibody Drug Conjugate Sales Forecast by Country (2027-2032) & (k units) Table 100. Europe HER2 Antibody Drug Conjugate Sales Market Share Forecast by Country (2027-2032) Table 101. Europe HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe HER2 Antibody Drug Conjugate Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe HER2 Antibody Drug Conjugate Market Share by Country (2021-2026) Table 104. Europe HER2 Antibody Drug Conjugate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe HER2 Antibody Drug Conjugate Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific HER2 Antibody Drug Conjugate Sales by Country (2021-2026) & (k units) Table 108. Asia-Pacific HER2 Antibody Drug Conjugate Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific HER2 Antibody Drug Conjugate Sales Forecast by Country (2027-2032) & (k units) Table 110. Asia-Pacific HER2 Antibody Drug Conjugate Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific HER2 Antibody Drug Conjugate Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific HER2 Antibody Drug Conjugate Market Share by Country (2021-2026) Table 114. Asia-Pacific HER2 Antibody Drug Conjugate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific HER2 Antibody Drug Conjugate Market Share Forecast by Country (2027-2032) Table 116. Latin America HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Latin America HER2 Antibody Drug Conjugate Sales by Country (2021-2026) & (k units) Table 118. Latin America HER2 Antibody Drug Conjugate Sales Market Share by Country (2021-2026) Table 119. Latin America HER2 Antibody Drug Conjugate Sales Forecast by Country (2027-2032) & (k units) Table 120. Latin America HER2 Antibody Drug Conjugate Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America HER2 Antibody Drug Conjugate Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America HER2 Antibody Drug Conjugate Market Share by Country (2021-2026) Table 124. Latin America HER2 Antibody Drug Conjugate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America HER2 Antibody Drug Conjugate Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa HER2 Antibody Drug Conjugate Sales by Country (2021-2026) & (k units) Table 128. Middle East and Africa HER2 Antibody Drug Conjugate Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa HER2 Antibody Drug Conjugate Sales Forecast by Country (2027-2032) & (k units) Table 130. Middle East and Africa HER2 Antibody Drug Conjugate Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa HER2 Antibody Drug Conjugate Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa HER2 Antibody Drug Conjugate Market Share by Country (2021-2026) Table 134. Middle East and Africa HER2 Antibody Drug Conjugate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa HER2 Antibody Drug Conjugate Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. HER2 Antibody Drug Conjugate Distributors List Table 139. HER2 Antibody Drug Conjugate Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. HER2 Antibody Drug Conjugate Image Figure 2. Global HER2 Antibody Drug Conjugate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HER2 Antibody Drug Conjugate Market Size (2021-2032) & (US$ Million) Figure 4. Global HER2 Antibody Drug Conjugate Sales (2021-2032) & (k units) Figure 5. 100mg/ bottle Image Figure 6. Global 100mg/ bottle Sales YoY Growth (2021-2032) & (k units) Figure 7. 440mg/ bottle Image Figure 8. Global 440mg/ bottle Sales YoY Growth (2021-2032) & (k units) Figure 9. Global HER2 Antibody Drug Conjugate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global HER2 Antibody Drug Conjugate Market Share by Type 2025 VS 2032 Figure 11. North America HER2 Antibody Drug Conjugate Sales Market Share in Volume by Type in 2025 Figure 12. North America HER2 Antibody Drug Conjugate Sales Market Share in Value by Type in 2025 Figure 13. Europe HER2 Antibody Drug Conjugate Sales Market Share in Volume by Type in 2025 Figure 14. Europe HER2 Antibody Drug Conjugate Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific HER2 Antibody Drug Conjugate Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific HER2 Antibody Drug Conjugate Sales Market Share in Value by Type in 2025 Figure 17. Latin America HER2 Antibody Drug Conjugate Sales Market Share in Volume by Type in 2025 Figure 18. Latin America HER2 Antibody Drug Conjugate Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa HER2 Antibody Drug Conjugate Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa HER2 Antibody Drug Conjugate Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 HER2 Antibody Drug Conjugate Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global HER2 Antibody Drug Conjugate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global HER2 Antibody Drug Conjugate Market Share by Application 2025 VS 2032 Figure 31. North America HER2 Antibody Drug Conjugate Sales Market Share in Volume by Application in 2025 Figure 32. North America HER2 Antibody Drug Conjugate Sales Market Share in Value by Application in 2025 Figure 33. Europe HER2 Antibody Drug Conjugate Sales Market Share in Volume by Application in 2025 Figure 34. Europe HER2 Antibody Drug Conjugate Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific HER2 Antibody Drug Conjugate Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific HER2 Antibody Drug Conjugate Sales Market Share in Value by Application in 2025 Figure 37. Latin America HER2 Antibody Drug Conjugate Sales Market Share in Volume by Application in 2025 Figure 38. Latin America HER2 Antibody Drug Conjugate Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa HER2 Antibody Drug Conjugate Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa HER2 Antibody Drug Conjugate Sales Market Share in Value by Application in 2025 Figure 41. North America HER2 Antibody Drug Conjugate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America HER2 Antibody Drug Conjugate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America HER2 Antibody Drug Conjugate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America HER2 Antibody Drug Conjugate Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe HER2 Antibody Drug Conjugate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe HER2 Antibody Drug Conjugate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe HER2 Antibody Drug Conjugate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe HER2 Antibody Drug Conjugate Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific HER2 Antibody Drug Conjugate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific HER2 Antibody Drug Conjugate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific HER2 Antibody Drug Conjugate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific HER2 Antibody Drug Conjugate Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America HER2 Antibody Drug Conjugate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America HER2 Antibody Drug Conjugate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America HER2 Antibody Drug Conjugate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America HER2 Antibody Drug Conjugate Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa HER2 Antibody Drug Conjugate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa HER2 Antibody Drug Conjugate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa HER2 Antibody Drug Conjugate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa HER2 Antibody Drug Conjugate Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. HER2 Antibody Drug Conjugate Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. HER2 Antibody Drug Conjugate Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg/ bottle
  • 440mg/ bottle
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • RemeGen
  • Roche
  • Daiichi Sankyo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HER2 Antibody Drug Conjugate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global HER2 Antibody Drug Conjugate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 HER2 Antibody Drug Conjugate Market by Type
  6. 1.3.1 100mg/ bottle
  7. 1.3.2 440mg/ bottle
  8. 1.4 Global HER2 Antibody Drug Conjugate Market Size by Type
  9. 1.4.1 Global HER2 Antibody Drug Conjugate Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global HER2 Antibody Drug Conjugate Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global HER2 Antibody Drug Conjugate Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America HER2 Antibody Drug Conjugate Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe HER2 Antibody Drug Conjugate Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific HER2 Antibody Drug Conjugate Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America HER2 Antibody Drug Conjugate Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa HER2 Antibody Drug Conjugate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 HER2 Antibody Drug Conjugate Industry Trends
  2. 2.2 HER2 Antibody Drug Conjugate Industry Drivers
  3. 2.3 HER2 Antibody Drug Conjugate Industry Opportunities and Challenges
  4. 2.4 HER2 Antibody Drug Conjugate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by HER2 Antibody Drug Conjugate Revenue (2021-2026)
  2. 3.2 Global Top Players by HER2 Antibody Drug Conjugate Sales (2021-2026)
  3. 3.3 Global Top Players by HER2 Antibody Drug Conjugate Price (2021-2026)
  4. 3.4 Global HER2 Antibody Drug Conjugate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global HER2 Antibody Drug Conjugate Major Company Production Sites & Headquarters
  6. 3.6 Global HER2 Antibody Drug Conjugate Company, Product Type & Application
  7. 3.7 Global HER2 Antibody Drug Conjugate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global HER2 Antibody Drug Conjugate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 HER2 Antibody Drug Conjugate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 HER2 Antibody Drug Conjugate Tier 1, Tier 2, and Tier 3
4 HER2 Antibody Drug Conjugate Regional Status and Outlook
  1. 4.1 Global HER2 Antibody Drug Conjugate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global HER2 Antibody Drug Conjugate Historic Market Size by Region
  3. 4.2.1 Global HER2 Antibody Drug Conjugate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global HER2 Antibody Drug Conjugate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global HER2 Antibody Drug Conjugate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global HER2 Antibody Drug Conjugate Forecasted Market Size by Region
  7. 4.3.1 Global HER2 Antibody Drug Conjugate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global HER2 Antibody Drug Conjugate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global HER2 Antibody Drug Conjugate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 HER2 Antibody Drug Conjugate by Application
  1. 5.1 HER2 Antibody Drug Conjugate Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global HER2 Antibody Drug Conjugate Market Size by Application
  6. 5.2.1 Global HER2 Antibody Drug Conjugate Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global HER2 Antibody Drug Conjugate Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global HER2 Antibody Drug Conjugate Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America HER2 Antibody Drug Conjugate Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe HER2 Antibody Drug Conjugate Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific HER2 Antibody Drug Conjugate Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America HER2 Antibody Drug Conjugate Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa HER2 Antibody Drug Conjugate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 RemeGen
  2. 6.1.1 RemeGen Company Information
  3. 6.1.2 RemeGen Business Overview
  4. 6.1.3 RemeGen HER2 Antibody Drug Conjugate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 RemeGen HER2 Antibody Drug Conjugate Product Portfolio
  6. 6.1.5 RemeGen Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche HER2 Antibody Drug Conjugate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche HER2 Antibody Drug Conjugate Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Daiichi Sankyo
  14. 6.3.1 Daiichi Sankyo Company Information
  15. 6.3.2 Daiichi Sankyo Business Overview
  16. 6.3.3 Daiichi Sankyo HER2 Antibody Drug Conjugate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Daiichi Sankyo HER2 Antibody Drug Conjugate Product Portfolio
  18. 6.3.5 Daiichi Sankyo Recent Developments
7 North America by Country
  1. 7.1 North America HER2 Antibody Drug Conjugate Sales by Country
  2. 7.1.1 North America HER2 Antibody Drug Conjugate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America HER2 Antibody Drug Conjugate Sales by Country (2021-2026)
  4. 7.1.3 North America HER2 Antibody Drug Conjugate Sales Forecast by Country (2027-2032)
  5. 7.2 North America HER2 Antibody Drug Conjugate Market Size by Country
  6. 7.2.1 North America HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America HER2 Antibody Drug Conjugate Market Size by Country (2021-2026)
  8. 7.2.3 North America HER2 Antibody Drug Conjugate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe HER2 Antibody Drug Conjugate Sales by Country
  2. 8.1.1 Europe HER2 Antibody Drug Conjugate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe HER2 Antibody Drug Conjugate Sales by Country (2021-2026)
  4. 8.1.3 Europe HER2 Antibody Drug Conjugate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe HER2 Antibody Drug Conjugate Market Size by Country
  6. 8.2.1 Europe HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe HER2 Antibody Drug Conjugate Market Size by Country (2021-2026)
  8. 8.2.3 Europe HER2 Antibody Drug Conjugate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific HER2 Antibody Drug Conjugate Sales by Country
  2. 9.1.1 Asia-Pacific HER2 Antibody Drug Conjugate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific HER2 Antibody Drug Conjugate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific HER2 Antibody Drug Conjugate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific HER2 Antibody Drug Conjugate Market Size by Country
  6. 9.2.1 Asia-Pacific HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific HER2 Antibody Drug Conjugate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific HER2 Antibody Drug Conjugate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America HER2 Antibody Drug Conjugate Sales by Country
  2. 10.1.1 South America HER2 Antibody Drug Conjugate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America HER2 Antibody Drug Conjugate Sales by Country (2021-2026)
  4. 10.1.3 South America HER2 Antibody Drug Conjugate Sales Forecast by Country (2027-2032)
  5. 10.2 South America HER2 Antibody Drug Conjugate Market Size by Country
  6. 10.2.1 South America HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America HER2 Antibody Drug Conjugate Market Size by Country (2021-2026)
  8. 10.2.3 South America HER2 Antibody Drug Conjugate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa HER2 Antibody Drug Conjugate Sales by Country
  2. 11.1.1 Middle East and Africa HER2 Antibody Drug Conjugate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa HER2 Antibody Drug Conjugate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa HER2 Antibody Drug Conjugate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa HER2 Antibody Drug Conjugate Market Size by Country
  6. 11.2.1 Middle East and Africa HER2 Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa HER2 Antibody Drug Conjugate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa HER2 Antibody Drug Conjugate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 HER2 Antibody Drug Conjugate Value Chain Analysis
  2. 12.1.1 HER2 Antibody Drug Conjugate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 HER2 Antibody Drug Conjugate Production Mode & Process
  7. 12.2 HER2 Antibody Drug Conjugate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 HER2 Antibody Drug Conjugate Distributors
  10. 12.2.3 HER2 Antibody Drug Conjugate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst